HPMA copolymer–aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HPMA copolymer–aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines

Published:2005-09 Issue:8-9 Volume:13 Page:459-470
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Greco Francesca¹,Vicent María J.²,Penning Neal A.³,Nicholson Robert I.¹,Duncan Ruth³

Affiliation:

1. Welsh School of Pharmacy, Redwood Building, Cardiff University, Tenovus Centre for Cancer Research, King Edward VII Avenue, Cardiff, CF10 3XF, UK

2. Centro de Investigación Príncipe Felipe-FVIB, Av. Autopista del Saler 16, E-46013, Valencia, Spain

3. Welsh School of Pharmacy, Redwood Building, Cardiff University, Centre for Polymer Therapeutics, King Edward VII Avenue, Cardiff, CF10 3XF, UK

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/10611860500383788

Reference30 articles.

1. Aminoglutethimide

2. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

3. Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase

4. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymer Conjugate as the New Promising Drug Delivery System for Combination Therapy against Cancer;Current Topics in Medicinal Chemistry;2024-05

2. Drug–polymer conjugates: Challenges, opportunities, and future prospects in clinical trials;Polymer-Drug Conjugates;2023

3. Nanocarriers for Smart Therapeutic Strategies to Treat Drug-Resistant Tumors: A Review;ASSAY and Drug Development Technologies;2022-07-01

4. Nanomedicine-Based Combinational Therapy for Breast Cancer;Hormone Related Cancer Mechanistic and Nanomedicines;2022

5. Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation;Advanced Drug Delivery Reviews;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3